0.5422

7.62% -0.0447

Mdxhealth Sa (MDXH)

Overview News Price History Discussions Forecast

Mdxhealth Sa stock is traded at $0.5422, with a volume of 583.76K. It is down -7.62% in the last 24 hours and down -71.01% over the past month. MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and the prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA) and Europe.

Previous Close:

$0.5869

Open:

$0.5952

24h Volume:

583.76K

Relative Volume:

1.00

Market Cap:

$27.85M

Revenue:

$110.97M

Net Income/Loss:

$-33.18M

P/E Ratio:

-0.8248

EPS:

-0.6574

Net Cash Flow:

$-11.80M

1W Performance:

-4.19%

1M Performance:

-71.01%

6M Performance:

-83.67%

1Y Performance:

-74.66%

1-Day Range:

$0.536

$0.5952

1-Week Range:

$0.52

$0.60

52-Week Range:

$0.51

$5.33

Mdxhealth Sa Stock (MDXH) Company Profile

Name

Mdxhealth Sa

Sector

Healthcare (1109)

Industry

Diagnostics & Research (50)

Phone

Address

Employee

364

Twitter

Next Earnings Date

2026-08-04

Latest SEC Filings

MDXH's Discussions on Twitter

Compare MDXH vs TMO, DHR, IDXX, A, WAT

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
MDXH Mdxhealth Sa	0.5422	27.85M	110.97M	-33.18M	-11.80M	-0.6574
TMO Thermo Fisher Scientific Inc	469.34	174.42B	45.20B	6.87B	6.75B	18.19
DHR Danaher Corp	180.10	127.47B	24.78B	3.68B	5.29B	5.1743
IDXX Idexx Laboratories Inc	560.88	44.24B	4.45B	1.10B	1.06B	13.59
A Agilent Technologies Inc	129.84	36.67B	7.23B	1.41B	1.09B	4.979
WAT Waters Corp	355.53	34.91B	3.77B	449.25M	240.68M	7.8556

Mdxhealth Sa Stock (MDXH) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jul-17-25	Initiated	Craig Hallum	Buy
Oct-31-24	Initiated	Lake Street	Buy
May-31-23	Initiated	TD Cowen	Outperform
Jul-18-22	Resumed	Oppenheimer	Outperform

Mdxhealth Sa Stock (MDXH) Latest News

Jun 08, 2026

· Analyst Forecast - MLQ.ai

Jun 08, 2026

Jun 03, 2026

MDxHealth (MDXH) director Michael Holder receives 10,000 share option grant - Stock Titan

Jun 03, 2026

MDxHealth (NASDAQ: MDXH) grants Joseph Sollee 237,100 share options - Stock Titan

Jun 03, 2026

Director Don M. Hardison granted 10,000 MDxHealth (MDXH) options at $0.76 - Stock Titan

Jun 03, 2026

MDxHealth (MDXH) awards new share options to finance VP - Stock Titan

Jun 03, 2026

MDxHealth (NASDAQ: MDXH) CEO granted 942,200 share options at $0.76 strike - Stock Titan

Jun 03, 2026

MDxHealth (MDXH) director-linked entity receives 10,000 share options at $0.76 - Stock Titan

Jun 03, 2026

MDxHealth (NASDAQ: MDXH) grants CCO John Bellano 333,000 share options - Stock Titan

Jun 03, 2026

MDxHealth (MDXH) director granted options on 10,000 shares - Stock Titan

Jun 03, 2026

MDxHealth (MDXH) director Koen Hoffman awarded 10,000 share options via Ahok BV - Stock Titan

Jun 03, 2026

May 29, 2026

MDxHealth (MDXH) Edges Higher as Stock Tests Key Resistance Near $0.80Sentiment Shift - thelegaladvocate.com

May 29, 2026

May 28, 2026

MDxHealth (MDXH) VP Brendan O’Connell files initial Form 3 ownership report - Stock Titan

May 28, 2026

May 26, 2026

MDxHealth (MDXH) Slides 6.25% as Cancer Diagnostics Stock Tests Key Support LevelEnding Diagonal - thelegaladvocate.com

May 26, 2026

May 25, 2026

MDxHealth to Shut Down Resolve UTI Business - Orange County Business Journal

May 25, 2026

May 22, 2026

MDXHealth Q1 2026 Earnings: EPS Miss Weighs on Shares as Company Navigates Diagnostic MarketEarnings Call Transcript - The Legal Advocate

May 22, 2026

May 21, 2026